EurekAlert! Cancer Research - News Releases

News Releases

Updates every hour. Last Updated: 13-Jul-2025 18:11 ET (13-Jul-2025 22:11 GMT/UTC)

AI could help improve early detection of interval breast cancers

University of California - Los Angeles Health Sciences
Peer-Reviewed Publication

A new study led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center suggests that artificial intelligence (AI) could help detect interval breast cancers before they become more advanced and harder to treat.

Journal: JNCI Journal of the National Cancer Institute
Funder: NIH/National Institutes of Health, NIH/National Cancer Institute, Agency for Healthcare Research and Quality, Early Diagnostics Inc

Consumption of ultra-processed foods by children up to one year old favors harmful bacteria in the gut

Fundação de Amparo à Pesquisa do Estado de São Paulo
Peer-Reviewed Publication

Analysis of the gut microbiota of more than 700 babies also showed that breastfeeding was a protective factor, mitigating the problem in those who consumed industrialized products. The study underscores the importance of breastfeeding and avoiding foods high in sugar, saturated fat, salt and chemical additives.

Journal: Clinical Nutrition
Funder: Fundação de Amparo à Pesquisa do Estado de São Paulo

Cancer studies present at Digestive Disease Week

Digestive Disease Week
Reports and Proceedings

Reporters note: The following briefs highlight selected cancer-related studies being presented at Digestive Disease Week® (DDW) 2025 in San Diego. You are welcome to use these items as-is, incorporate them into broader coverage, or use them as story starters for your own reporting. Reach out to Tware@thereisgroup.com to get more information or to connect with researchers for interviews.

Embargo: Each brief is embargoed until 12:01 a.m. PDT the day of its presentation, as listed at the end of each item. Alternatively, the entire package may be published after 12:01 a.m. PDT on May 5, 2025.

Meeting: Digestive Disease Week

Liver cancer survival rates reflect income disparities

University of Gothenburg
Peer-Reviewed Publication

The risk of dying from the most common form of primary liver cancer is about 30 percent higher for patients with low household income compared to those with middle or high household income, according to a study at the University of Gothenburg.

Journal: The Lancet Regional Health - Europe

New radiotherapy technique aims to protect the heart during lung cancer treatment

European Society for Radiotherapy and Oncology (ESTRO)
Peer-Reviewed Publication

The RAPID-RT study, led by researchers at The Christie NHS Foundation Trust in Manchester, UK, evaluates the impact of modifying radiotherapy treatments in real-world lung cancer patients. Specifically, the study explores whether reducing the dose to the top of the heart—an area known to be sensitive to radiation—can improve survival rates by minimizing cardiac toxicity typically associated with conventional radiotherapy.

Journal: Radiotherapy and Oncology
Meeting: ESTRO 2025

Phase III trial shows molecular profiling can safely reduce radiation for women with endometrial cancer and optimise treatment for patients at a higher risk patients

European Society for Radiotherapy and Oncology (ESTRO)
Peer-Reviewed Publication

A major international study, PORTEC-4a, provides the strongest evidence yet that molecular profiling can safely reduce radiotherapy for women with early stage endometrial cancer while identifying those who would benefit from more intensive treatment. The results, that will be presented at ESTRO 2025, the annual congress of the European Society for Radiotherapy and Oncology (ESTRO), mark a significant step forward in personalised cancer treatment.

Journal: Radiotherapy and Oncology
Meeting: ESTRO 2025

Five major advances in anal and rectal cancer treatment with radiotherapy

European Society for Radiotherapy and Oncology (ESTRO)
Peer-Reviewed Publication

Fiive pivotal studies presented at ESTRO 2025, the annual congress of the European Society for Radiotherapy and Oncology, showcase how radiotherapy is reshaping anal and rectan cancers treatment approaches. From reduced-dose treatments to cutting-edge combinations with immunotherapy and chemotherapy, these innovations offer safer, more effective, and organ-preserving alternatives to traditional surgery.

Meeting: ESTRO 2025

Turning point in stomach cancer: Early-stage diagnoses now more common

Digestive Disease Week
Reports and Proceedings

Retrospective study examines changes in early-stage stomach cancer detection over the past two decades, as stomach cancer remains one of the deadliest cancers globally.

Meeting: Digestive Disease Week

Anal cancer rates rising most among older, white and Hispanic women

Digestive Disease Week
Reports and Proceedings

Rates of anal cancer continue to steadily increase in the U.S. with the largest jump among older women.

Meeting: Digestive Disease Week

Two-week radiotherapy proven as safe and effective as eight-week course for prostate cancer, after 10-year follow-up in phase III trial

European Society for Radiotherapy and Oncology (ESTRO)
Peer-Reviewed Publication

The phase III study shows that giving prostate cancer patients fewer, higher doses of radiotherapy can be safe and effective in the long term.

Journal: Radiotherapy and Oncology
Meeting: ESTRO 2025

78
79
80
81
82